Abstract:Brain synaptic terminals and neuronal plasma membranes are highly enriched in docosahexaenoic acid (DHA; C22:6, n=3), and deficiencies in this essential omega-3 polyunsaturated fatty acid are symptomatic of Alzheimer's disease (AD) brain. Neuroprotectin D1 (NPD1), the first characterized oxygenated derivative of DHA, displays remarkable anti-inflammatory and neurotrophic properties in AD models. These studies examined key players in an intrinsic DHA-NPD1 mediated rescue system that include the neuronal transmembrane sorting receptor sortilin-1 (SORL1/LR11), the α-secretase-processed neurotrophin sAPPα, and a tandem cytosolic phospholipase A2 15-lipoxygenase (cPLA2-15-LOX) enzymatic system that biosynthesizes NPD1 in human brain cells. AD and age-matched control short post-mortem (< 5 hr) brain tissue; IL-1β, Aβ42 and ROS-stressed human neural (HN) cells in primary culture; high-fat cholesterol (HFC) diet stressed Tg2576 mice; total DNA, RNA and protein isolation and quality control; LC-PDA-ESI-MS-MS; DNA arrays (mRNA; Affymetrix, Santa Clara, CA); Northern analysis; RT-PCR; Western immunoblotting; gel shift assay; Hoechst 33258 staining/fluorescence microscopy; specific NF–κB and inflammatory transcription factor repression; bioinformatics. AD neocortex and hippocampus, as well as [IL-1β+Aβ42] or ROS-stressed HN cells in primary culture, were found to be depleted of DHA and NPD1. In HN cells DHA and NPD1 were found to stimulate sAPPα production and reduce Aβ42 peptide shedding from these cells. The tandem cPLA2-15LOX enzymatic system generating NPD1 was found to be stimulated in DHA treated HN cells. Reduced SORL1, a regulator of the intracellular trafficking of βAPP, coupled to elevated PS1, increased Aβ42 peptide secretion and up-regulated inflammatory and apoptotic signaling, were observed in [IL-1β+Aβ42]-stressed HN cells and in HFC-stressed Tg2576 mouse brain. Homeostatic SORL1 levels were found to be restored after DHA-NPD1 supplementation. Significant advancements in our understanding of cell-survival signaling in AD stem from recent investigations into the metabolism, trafficking and fate of DHA and NPD1. Current studies support the idea that DHA itself and novel DHA-derived neural synapse- and membrane-derived lipid messengers such as NPD1 have considerable potential to modulate cell survival. DHA and NPD1, intrinsically triggered biolipid neuroprotectants along with their associated rescue pathways, appear to contribute to life-or-death decisions of brain cells during homoeostasis, aging and neurodegenerative disease.

P2-396: Docosahexaenoic Acid and Neuroprotectin D1 Signaling in Alzheimer's Disease Brain and in Alzheimer Models

Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival Via Secretase- and PPARγ-mediated Mechanisms in Alzheimer's Disease Models.

Neuroprotectin D1 Exerts Potent Anti‐apoptotic and Anti‐amyloidogenic Effects in Human Neural Cell Models of Alzheimer's Disease

Increasing the Survival of a Neuronal Model of Alzheimer's Disease Using Docosahexaenoic Acid, Restoring Endolysosomal Functioning by Modifying the Interactions between the Membrane Proteins C99 and Rab5

Endogenous Docosahexaenoic Acid (DHA) Prevents Aβ1–42 Oligomer-Induced Neuronal Injury

DHA-PC and DHA-PS Improved Aβ1–40 Induced Cognitive Deficiency Uncoupled with an Increase in Brain DHA in Rats

The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models.

DHA Ameliorates Cognitive Ability, Reduces Amyloid Deposition, and Nerve Fiber Production in Alzheimer’s Disease

Brain response to injury and neurodegeneration: endogenous neuroprotective signaling

A New Chiral Pyrrolyl Alpha-Nitronyl Nitroxide Radical Attenuates Beta-Amyloid Deposition And Rescues Memory Deficits In A Mouse Model Of Alzheimer Disease

A Comparative Study about the Neuroprotective Effects of DHA-Enriched Phosphatidylserine and EPA-Enriched Phosphatidylserine Against Oxidative Damage in Primary Hippocampal Neurons.

Docosahexaenoic (DHA) modulates phospholipid-hydroperoxide glutathione peroxidase (Gpx4) gene expression to ensure self-protection from oxidative damage in hippocampal cells

DHA Diet Reduces AD Pathology in Young APPswe/PS1ΔE9 Transgenic Mice: Possible Gender Effects

Mechanisms of DHA-enriched Phospholipids in Improving Cognitive Deficits in Aged SAMP8 Mice with High-Fat Diet

Novel mechanisms to enhance omega‐3 brain metabolism with APOE4

Up-regulation of myelin-associated glycoprotein is associated with the ameliorating effect of Omega-3 polyunsaturated fatty acids on Alzheimer's disease progression in APP-PS1 transgenic mice

Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease

Docosahexaenoic Acid-Phosphatidylcholine Improves Cognitive Deficits in an Aβ23-35-Induced Alzheimer's Disease Rat Model.

NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restores Synaptic Structures in APP/PS1 Transgenic Mice

Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect

Metabotyping of Docosahexaenoic Acid - Treated Alzheimer’s Disease Cell Model